Successful anti-TB treatment results in restoration of Mtb-specific CD8+T cell function, the proportions can return to normal levels, but its limited proliferative function, a part of T cell progressive development exhaustion, may not be fully restored with the progress of treatment (Day et al., 2014). The gene discussed is CD8A; the disease is tuberculosis.